Proteomic characterization of esophageal squamous cell carcinoma response to immunotherapy reveals potential therapeutic strategy and predictive biomarkers.
Ma F, Li Y, Xiang C, Wang B, Lv J, Wei J, Qin Z, Pu Y, Li K, Teng H, Tan S, Feng J, Shang Z, Wang Y, Tian S, Du C, Han Y, Ding C.
Ma F, et al. Among authors: li y, li k.
J Hematol Oncol. 2024 Mar 15;17(1):11. doi: 10.1186/s13045-024-01534-9.
J Hematol Oncol. 2024.
PMID: 38491392
Free PMC article.